• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例老年肢端肥大症患者的病例报告。

A case report of an elderly patient with acromegaly.

作者信息

Wada M, Azuma H, Bando H, Shintani Y, Saito S, Tamaki M, Arii H

机构信息

First Department of Internal Medicine, School of Medicine, University of Tokushima, Japan.

出版信息

Endocr J. 1996 Dec;43(6):715-8. doi: 10.1507/endocrj.43.715.

DOI:10.1507/endocrj.43.715
PMID:9075612
Abstract

We encountered a 91-year-old patient with acromegalic features. The serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) were increased to 23.3 ng/ml and to 268 ng/ml, respectively. Both thyrotropin-releasing hormone and luteinizing hormone-releasing hormone tests demonstrated a 2-3 fold increase in the serum GH level. Magnetic resonance imaging disclosed a pituitary mass in the enlarged sella. The patient was diagnosed as having acromegaly due to overproduction of GH from a pituitary tumor. She manifested cardiac hypertrophy with severe aortic stenosis and mild hypertension, but without diabetes mellitus. After the administration of octreotide subcutaneously at a dose of 25 to 50 micrograms daily for 20 days, the serum GH level increased transiently but decreased rapidly to approximately half the initial level, and suppression of the GH level persisted thereafter for over 2.5 months. This patient seems to be the oldest patient with acromegaly among those reported in Japan.

摘要

我们遇到了一位具有肢端肥大症特征的91岁患者。生长激素(GH)和胰岛素样生长因子-I(IGF-I)的血清水平分别升高至23.3 ng/ml和268 ng/ml。促甲状腺激素释放激素和促黄体生成素释放激素试验均显示血清GH水平升高了2至3倍。磁共振成像显示扩大的蝶鞍内有垂体肿块。该患者被诊断为因垂体肿瘤过度分泌GH而患有肢端肥大症。她表现出心脏肥大,伴有严重的主动脉瓣狭窄和轻度高血压,但无糖尿病。每日皮下注射25至50微克奥曲肽,持续20天,血清GH水平短暂升高,但迅速下降至初始水平的约一半,此后GH水平的抑制持续超过2.5个月。该患者似乎是日本报道的患肢端肥大症的最年长患者。

相似文献

1
A case report of an elderly patient with acromegaly.一例老年肢端肥大症患者的病例报告。
Endocr J. 1996 Dec;43(6):715-8. doi: 10.1507/endocrj.43.715.
2
Effects of treatment with octreotide in acromegalic patients--a multicenter Italian study. Italian Multicenter Octreotide Study Group.奥曲肽治疗肢端肥大症患者的疗效——一项意大利多中心研究。意大利多中心奥曲肽研究组
Eur J Endocrinol. 1995 Oct;133(4):430-9. doi: 10.1530/eje.0.1330430.
3
Octreotide as primary therapy for acromegaly.奥曲肽作为肢端肥大症的主要治疗方法。
J Clin Endocrinol Metab. 1998 Sep;83(9):3034-40. doi: 10.1210/jcem.83.9.5109.
4
Acromegaly with normal IGF-1 levels probably due to poorly controlled diabetes mellitus.肢端肥大症伴胰岛素样生长因子-1(IGF-1)水平正常,可能是由于糖尿病控制不佳所致。
Tohoku J Exp Med. 2008 Dec;216(4):325-9. doi: 10.1620/tjem.216.325.
5
Bromocriptine, a dopamine agonist, increases growth hormone secretion in a patient with acromegaly.溴隐亭,一种多巴胺激动剂,可增加一名肢端肥大症患者的生长激素分泌。
Tohoku J Exp Med. 2014 Oct;234(2):129-35. doi: 10.1620/tjem.234.129.
6
Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.奥曲肽鼻粉长期治疗对肢端肥大症患者血清生长激素、胰岛素样生长因子I、胰岛素样生长因子结合蛋白1和3水平的影响。
J Endocrinol Invest. 1996 Sep;19(8):548-55. doi: 10.1007/BF03349015.
7
Effects of initial therapy for five years with somatostatin analogs for acromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease: a prospective study.生长抑素类似物初始治疗五年对肢端肥大症患者生长激素和胰岛素样生长因子-I水平、肿瘤缩小及心血管疾病的影响:一项前瞻性研究
J Clin Endocrinol Metab. 2009 Oct;94(10):3746-56. doi: 10.1210/jc.2009-0941. Epub 2009 Jul 21.
8
The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex.肢端肥大症患者生长激素分泌对药物治疗的敏感性:年龄和性别的影响。
Clin Endocrinol (Oxf). 1992 Aug;37(2):181-5. doi: 10.1111/j.1365-2265.1992.tb02304.x.
9
Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.肢端肥大症的主要药物治疗:一项关于皮下和肌肉注射缓释奥曲肽对生长激素、胰岛素样生长因子-I及肿瘤大小影响的开放性、前瞻性、多中心研究
J Clin Endocrinol Metab. 2002 Oct;87(10):4554-63. doi: 10.1210/jc.2001-012012.
10
[Experience in treating acromegalic patients with long-acting octreotide].[长效奥曲肽治疗肢端肥大症患者的经验]
Orv Hetil. 2002 May 12;143(19 Suppl):1066-70.

引用本文的文献

1
Severe arterial hypertension: a possible complication of McCune-Albright syndrome.重度动脉高血压:McCune-Albright综合征的一种可能并发症。
Eur J Pediatr. 2009 Jul;168(7):871-6. doi: 10.1007/s00431-008-0848-1. Epub 2008 Oct 29.